BAY 81-8973 is an unmodified, full-length third generation recombinant factor VIII (rFVIII) which offers a more favorable pharmacokinetic (PK) profile, compared to its predecessor sucrose-formulated rFVIII (rFVIII-FS). We here report on a retrospective case series of nine patients affected by hemophilia A (HA), with variable disease severity, bleeding phenotype and comorbidities, to underline our clinical practice on prophylaxis with a recently introduced standard hall-life recombinant Factor VIII. The current case series highlights how the current clinical management of hemophilia is able to personalize treatment in several specific conditions like concomitant illnesses with thrombotic risk and allergic reactions.

Santoro, R.C., Giuffrida, G., Daniele, F., Gagliano, F., Mansueto, M.F., Calafiore, V., et al. (2020). Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series. TRANSFUSION AND APHERESIS SCIENCE, 102897 [10.1016/j.transci.2020.102897].

Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series

Mansueto, Maria Francesca;Siragusa, Sergio;Napolitano, Mariasanta
Conceptualization
2020

Abstract

BAY 81-8973 is an unmodified, full-length third generation recombinant factor VIII (rFVIII) which offers a more favorable pharmacokinetic (PK) profile, compared to its predecessor sucrose-formulated rFVIII (rFVIII-FS). We here report on a retrospective case series of nine patients affected by hemophilia A (HA), with variable disease severity, bleeding phenotype and comorbidities, to underline our clinical practice on prophylaxis with a recently introduced standard hall-life recombinant Factor VIII. The current case series highlights how the current clinical management of hemophilia is able to personalize treatment in several specific conditions like concomitant illnesses with thrombotic risk and allergic reactions.
Santoro, R.C., Giuffrida, G., Daniele, F., Gagliano, F., Mansueto, M.F., Calafiore, V., et al. (2020). Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series. TRANSFUSION AND APHERESIS SCIENCE, 102897 [10.1016/j.transci.2020.102897].
File in questo prodotto:
File Dimensione Formato  
Santoro_Kovaltry_Trasf Apher Journal.pdf

accesso aperto

Descrizione: accepted article
Tipologia: Pre-print
Dimensione 443.48 kB
Formato Adobe PDF
443.48 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/430607
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact